Ms. Tami Wahl
Ms. Tami Wahl filed a Q1 report for Traditional Medicinals on April 17, 2026, reporting $10,000 in lobbying income.
Lobbying for Traditional Medicinals · Brand holder and manufacturer.
Monitoring the regulatory environment for, i) the dietary supplement category and market entry thresholds for same, ii) domestic manufacturing and tariff implications.
Explore the role of small businesses i) in the dietary supplement category and needs of same for market entry, and ii) in domestic manufacturing and potential tariff implications.
Monitoring the regulatory environment for the dietary supplement category with domestic manufacturing capabilities and tariff implications.
Monitoring / mitigating tariff implications on components and equipment not available stateside for domestic manufacturing operations.